Market Place
Sourcing Support
Hetero`s Generics Azacitidine Receives Approval in US
15 Oct 2024 //
FDA
73rd IPC inaugurated in Hyderabad, with emphasis on innovation and healthcare
05 Jul 2024 //
PHARMABIZ
Hetero Labs Vi Generic Pemetrexed Disodium Receives Approval in US
14 Jun 2024 //
FDA
Hetero Labs V Biologic Avanafil Receives Approval in US
14 Jun 2024 //
FDA
Hetero`s Generic Ospemifene Receives Approval in the U.S.
13 Feb 2024 //
FDA
Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
09 Jan 2024 //
FDA
Hetero`s Generic Apixaban Receives Approval in the U.S.
21 Nov 2023 //
FDA
Hetero`s Generic Eluxadoline Receives Approval in the U.S.
10 Aug 2023 //
FDA
Hetero`s Generic Allopurinol Receives Approval in the U.S.
03 Aug 2023 //
FDA
Hetero`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
03 Aug 2023 //
FDA
Hetero`s Generic Lenalidomide Receives Receives Approval in the U.S.
11 May 2023 //
FDA
Enforcement Report - Week of April 19, 2023
19 Apr 2023 //
FDA
Hetero`s Generic Teriflunomide Receives Approval in the U.S.
13 Mar 2023 //
FDA
Hetero to invest Rs 1,000 crore in AP over two years to expand pharma business
04 Mar 2023 //
ECONOMIC TIMES
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
26 Dec 2022 //
EXPRESSPHARMA
Hetero`s Generic Posaconazole Receives Approval in the U.S.
08 Dec 2022 //
FDA
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.